After the Supreme Court’s reversal of IEEPA tariffs, a new combination of Section 232 and Section 301 tariffs is rapidly reshaping the trade landscape for US importers. Legal and trade advisers at
Sun Pharmaceutical Industries Limited has unveiled a new educational campaign called Regrowth Restyled, aimed at supporting adults living with severe alopecia areata. The campaign launched during Alopecia Areata Awareness Month and takes
More
Patent holders seeking to sidestep the marking statute through clever settlement structuring are unlikely to find safe harbour in covenants not to sue. The central question is whether a patentee can avoid
More
The government is actively considering lowering the mansion tax threshold to properties worth over £1.5m, a move that would bring nearly 271,000 homes into scope. Labour originally introduced the levy on properties
More
The FTSE 100 index has long attracted criticism, with detractors branding it a “dinosaur index” and a “retirement home for companies” due to its lack of cutting-edge technology firms. There is some
More
New York Governor Kathy Hochul signed S.3460 into law on September 9, 2026, adding a new Section 210-b to the New York Labor Law, marking a significant shift in employee rights. The
More
France’s wine industry is confronting one of its gravest crises in living memory, with output set to reach levels not seen since the 1950s. The country’s agriculture ministry has warned that wine
More
Consultant Cheryl Donaldson, drawing on over three decades of clinical experience, is challenging law firms to rethink what actually keeps talented lawyers from walking out the door. Business development coach and podcaster
More
Goldman Sachs has identified a surprising culprit behind persistently poor consumer sentiment readings: a broad societal decline in happiness. The consumer sentiment index tracked by the University of Michigan hit record lows
More
Eli Lilly (LLY) has secured a second FDA approval for its oral SERD Inluriyo in under a year, this time in combination with its CDK4/6 inhibitor Verzenio. The regimen is now approved
More
The U.S. Court of Appeals for the Second Circuit has amended a recent ruling, bringing significant clarity to Title VII religious accommodation cases across the circuit. The amended decision, issued on September
More